Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes

Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes

Bibliographic Details
Main Authors:	Dhanaji M. Lade, Yehenew M. Agazie
Format:	Article
Language:	English
Published:	American Chemical Society 2023-07-01
Series:	ACS Bio & Med Chem Au
Online Access:	https://doi.org/10.1021/acsbiomedchemau.3c00024

Similar Items

Off‐target inhibition by active site‐targeting SHP2 inhibitors
by: Ryouhei Tsutsumi, et al.
Published: (2018-09-01)

Corrigendum to: Off‐target inhibition by active site‐targeting SHP2 inhibitors
by: Ryouhei Tsutsumi, et al.
Published: (2019-12-01)

Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors
by: Guus J. J. E. Heynen, et al.
Published: (2022-04-01)

The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines
by: Rose Ghemrawi, et al.
Published: (2022-04-01)

Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling
by: Ziying Sun, et al.
Published: (2022-07-01)

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition
by: Xianning Lai, et al.
Published: (2023-12-01)

Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer
by: Chaofan Liu, et al.
Published: (2023-04-01)

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
by: Zhenzhen Fan, et al.
Published: (2020-06-01)

NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6Clow Monocytes/Macrophages Differentiation to Accelerate Thrombolysis
by: Kejing Ying, et al.
Published: (2024-04-01)

Consideration of SHP-1 as a Molecular Target for Tumor Therapy
by: Seyeon Lim, et al.
Published: (2023-12-01)

Mechanisms of synergistic suppression of ALK-positive lung cancer cell growth by the combination of ALK and SHP2 inhibitors
by: M. A. Berry, et al.
Published: (2023-06-01)

Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects.
by: Chris Jopling, et al.
Published: (2007-12-01)

PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?
by: Rossi Gian, et al.
Published: (2011-06-01)

Biophysical assay for tethered signaling reactions reveals tether-controlled activity for the phosphatase SHP-1
by: Goyette, J, et al.
Published: (2017)

The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?
by: Céline Saint-Laurent, et al.
Published: (2022-08-01)

SHP1-ing thymic selection
by: Gascoigne, N, et al.
Published: (2016)

SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer
by: Qian Geng, et al.
Published: (2022-04-01)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
by: Julia Taylor, et al.
Published: (2023-06-01)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
by: Xiaozheng Xu, et al.
Published: (2021-11-01)

Atomistic ensemble of active SHP2 phosphatase
by: Massimiliano Anselmi, et al.
Published: (2023-12-01)

Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97
by: Sebastian Bothe, et al.
Published: (2022-12-01)

SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling
by: Yuko Nagamura, et al.
Published: (2021-08-01)

576 Blocking FGFR2 and SHP2 can effectively suppress tumor progression in gastric cancers with FGFR2 alteration
by: Yue Wang, et al.
Published: (2023-11-01)

Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN
by: Hyeun-Wook Chang, et al.
Published: (2023-02-01)

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
by: Jae Hyung Park, et al.
Published: (2020-10-01)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
by: Matthew T.N. Yarnall, et al.
Published: (2022-12-01)

Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment
by: Adrianne L. Stefanski, et al.
Published: (2022-10-01)

Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
by: Angata, T, et al.
Published: (2002)

Developing SHP2-based combination therapy for KRAS-amplified cancer
by: Tianxia Li, et al.
Published: (2023-02-01)

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition
by: Jinyang Cai, et al.
Published: (2022-07-01)

Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl4-induced liver fibrosis
by: Yi Zhang, et al.
Published: (2023-02-01)

Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
by: Wenjun Ye, et al.
Published: (2022-05-01)

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
by: Nicole Spencer, et al.
Published: (2023-12-01)

Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
by: Mengjie Rui, et al.
Published: (2022-04-01)

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
by: Navid Sobhani, et al.
Published: (2021-02-01)

SHP2 potentiates anti-PD-1 effectiveness through intervening cell pyroptosis resistance in triple-negative breast cancer
by: Chao Chen, et al.
Published: (2023-12-01)

Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
by: Cornall, R, et al.
Published: (1999)

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling
by: Yuming Zhao, et al.
Published: (2023-01-01)

Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling
by: Vidyasiri Vemulapalli, et al.
Published: (2021-03-01)

Blocking channels to metastasis: targeting sodium transport in breast cancer
by: William J. Brackenbury, et al.
Published: (2023-11-01)